Solara Active Pharma Sciences Ltd.NSE: SOLARA

Press Release Nov 01 2022

· Issued by Solara Active Pharma Sciences Ltd.

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-nov-01-2022-28

Solara Active Pharma Sciences Limited has informed the Exchange about press release dated 01-Nov-2022 titled Solara receives European Approval (CEP) to manufacture Ibuprofen from its flagship Vizag facility

View Attachment

6ix hasn’t read this filing yet.

Solara Active Pharma Sciences Ltd. on 6ix

Earlier from Solara Active Pharma Sciences

Later from Solara Active Pharma Sciences

All Solara Active Pharma Sciences news releases